Key facts
- This page summarizes Jonathan E. Lim's Form 4 filing for Boundless Bio, Inc. (BOLD).
- 1 reported transaction and 1 derivative row are listed below.
- Filing timestamp: 29 Mar 2024, 16:30.
Jonathan E. Lim - 27 Mar 2024 Form 4 Insider Report for Boundless Bio, Inc. (BOLD)
- Role
- Director
- Signature
- /s/ Jessica Oien, Attorney-in-Fact for Jonathan Lim
- Issuer symbol
- BOLD
- Transactions as of
- 27 Mar 2024
- Net transactions value
- $0
- Form type
- 4
- Filing time
- 29 Mar 2024, 16:30:42 UTC
- Previous filing
- 07 Feb 2024
- Next filing
- 04 Apr 2024
- SEC
- View on sec.gov
Key filing fact
Jonathan E. Lim filed Form 4 for Boundless Bio, Inc. (BOLD) on 29 Mar 2024.
Change
- Previous filing in this sequence was filed on 07 Feb 2024.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
See Original Filing
Ownership activity is grounded in SEC Form 4 disclosures.
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
BOLD
transaction
Derivative
Stock Option
Award
- Transaction value
- $0
- Shares
- +13,219
- Change %
- Price
- $0.000000
- Shares after
- 13,219
- Date
- 27 Mar 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 13,219
- Exercise price
- $16.00
- Footnotes
- F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses:
| Id | Content |
|---|---|
| F1 | The stock option vests in 36 substantially equal monthly installments beginning on April 27, 2024. |